5033 CapSure Z |
Product Characteristics | |||
|---|---|---|---|---|
| US Market Release | Feb-96 | Serial Number Prefix | LDK | |
| Registered US Implants | 2,300 | Type and/or Fixation | Transvenous, Vent., Tines | |
| Estimated Active US Implants | 700 | Polarity | Unipolar | |
| Advisories | None | Steroid | Yes | |
| Ventricular Placement | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| System Longevity Study Results |
|
|||||||||||||
| Number of Leads Enrolled in Study | 1,899 | |||||||||||||
| Cumulative Months of Follow-Up | 78,676 | |||||||||||||
| Number of Leads Active in Study | 241 | |||||||||||||
| Qualifying Complications | 26 Total | |||||||||||||
| Cardiac Perforation | 1 | |||||||||||||
| Conductor Fracture | 7 | |||||||||||||
| Failure to Capture | 11 | |||||||||||||
| Impedance Out of Range | 4 | |||||||||||||
| Insulation (not further defined) | 1 | |||||||||||||
| Lead Dislodgement | 2 | |||||||||||||
